Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-014637-24Phase 2Completed
Phase 2, open-label, single-arm trial of IDflu in influenza, sponsored by IRCCS Ospedale Policlinico San Martino. Primary endpoints: Safety and tolerability of Intanza, Immunogenicity and 2 more. Started Aug 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-014637-24.